Submit Deal

G1 THERAPEUTICS

Summary

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 319 M

Avg. Deal Size£ 319 M

Market Context

Senior Management

Sort

Target: G1 THERAPEUTICS

Bidder: PHARMACOSMOS THERAPEUTICS

8 Service Providers

15 Dealmakers

£ 318 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy